Showing BioInteractions for Dalteparin (DB06779)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Dalteparin is a Vascular endothelial growth factor A inhibitor | ||
| 1 | Vascular endothelial growth factor A inhibitors | Brolucizumab, Minocycline, Vandetanib |
| 2 | Vascular endothelial growth factor A antagonists | Faricimab, Pegaptanib |
| 3 | Vascular endothelial growth factor A binders | Aflibercept |
| 4 | Vascular endothelial growth factor A agonists | Foreskin keratinocyte (neonatal) |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Dalteparin is a Tissue factor pathway inhibitor inhibitor | ||
| 1 | Tissue factor pathway inhibitor inhibitors | Andexanet alfa |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Dalteparin is a Antithrombin-III potentiator | ||
| 1 | Antithrombin-III potentiators | Ardeparin, Enoxaparin, Fondaparinux, Heparin, Nadroparin, Sulodexide, Tinzaparin |
| 2 | Antithrombin-III agonists | Antithrombin III human |
| 3 | Antithrombin-III antagonists | Bemiparin |
| 4 | Antithrombin-III positive allosteric modulators | Danaparoid |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Dalteparin is a P-selectin inhibitor | ||
| 1 | P-selectin inhibitors | Crizanlizumab, Heparin, Nadroparin |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Dalteparin is a Heparanase substrate | ||
| 1 | Heparanase substrates | Heparin |